Daiwa Securities Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13K Buy
602
+53
+10% +$1.15K ﹤0.01% 1110
2025
Q1
$9K Hold
549
﹤0.01% 1100
2024
Q4
$10K Sell
549
-92
-14% -$1.68K ﹤0.01% 1117
2024
Q3
$10K Buy
641
+90
+16% +$1.4K ﹤0.01% 1127
2024
Q2
$9K Sell
551
-100
-15% -$1.63K ﹤0.01% 1158
2024
Q1
$12K Hold
651
﹤0.01% 1149
2023
Q4
$20K Hold
651
﹤0.01% 1117
2023
Q3
$14K Hold
651
﹤0.01% 1106
2023
Q2
$16K Hold
651
﹤0.01% 1106
2023
Q1
$12K Hold
651
﹤0.01% 1090
2022
Q4
$10K Buy
651
+182
+39% +$2.8K ﹤0.01% 1107
2022
Q3
$8K Hold
469
﹤0.01% 1130
2022
Q2
$7K Hold
469
﹤0.01% 1139
2022
Q1
$11K Hold
469
﹤0.01% 1125
2021
Q4
$11K Sell
469
-81
-15% -$1.9K ﹤0.01% 1136
2021
Q3
$9K Buy
550
+233
+74% +$3.81K ﹤0.01% 1141
2021
Q2
$8K Hold
317
﹤0.01% 1045
2021
Q1
$8K Buy
317
+18
+6% +$454 ﹤0.01% 1050
2020
Q4
$16K Sell
299
-590
-66% -$31.6K ﹤0.01% 988
2020
Q3
$37K Buy
889
+20
+2% +$832 ﹤0.01% 949
2020
Q2
$37K Hold
869
﹤0.01% 912
2020
Q1
$37K Hold
869
﹤0.01% 964
2019
Q4
$37K Sell
869
-46
-5% -$1.96K ﹤0.01% 970
2019
Q3
$33K Hold
915
﹤0.01% 963
2019
Q2
$24K Hold
915
﹤0.01% 987
2019
Q1
$25K Sell
915
-37,773
-98% -$1.03M ﹤0.01% 972
2018
Q4
$625K Sell
38,688
-3,213
-8% -$51.9K 0.01% 538
2018
Q3
$870K Sell
41,901
-15,105
-26% -$314K 0.01% 522
2018
Q2
$870K Sell
57,006
-16,289
-22% -$249K 0.01% 507
2018
Q1
$1.65M Buy
73,295
+1,447
+2% +$32.5K 0.01% 407
2017
Q4
$2.16M Buy
+71,848
New +$2.16M 0.02% 369